Long non-coding RNAs as potential biomarkers or therapeutic targets in gastric cancer.
Gastroenterology and hepatology from bed to bench. · 01.01.2023 · 16 (3) · 297-306
DOI: 10.22037/ghfbb.v16i2.2701 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastroenterology and hepatology from bed to bench., erschienen am 01.01.2023. Verfasst von Nahid Askari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Institute of Sciences and High Technology and Environmental Sciences, Graduate University of Advanced Technology, End of…. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aim
This study aimed to find lncRNAs and mRNAs that were expressed differently by combining microarray datasets from different studies. This was done to find important target genes in gastric cancer for anti-cancer therapy.
Background
Gastric cancer (GC) is the fourth most frequent and second-most deadly malignancy worldwide. Thus, genetic diagnosis and treatment should focus on genetic and epigenetic variables. Based on several studies, disordered expression of non-coding RNAs (ncRNAs), such as lncRNAs, regulate gastric cancer invasion and metastasis. Besides, lncRNAs cooperatively regulate gene expression and GC progression.
Methods
We obtained differentially expressed mRNAs (DEmRNAs) and lncRNAs (DElncRNAs) from three GC tissue microarray datasets by meta-analysis and screened genes using the "Limma" package. Then, using the RNAInter database, we allocated DEmRNAs to each DElncRNA. ClusterProfiler and GOplot programs were used to analyze function enrichment pathways and gene ontologies for final DEmRNAs.
Results
A total of 9 differentially expressed lncRNAs (DElncRNAs) (5 up-regulated and 4 down-regulated), and 856 DEmRNAs (451 up-regulated and 405 down-regulated) between tumor and adjacent normal samples were found. Finally, 117 differentially expressed mRNAs were predicted as interactors of six DElncRNAs (H19, WT1-AS, EMX2OS, HOTAIR, ZEB1-AS1, and LINC00261).
Conclusion
In order to promote cancer therapeutics and give knowledge on the process of carcinogenesis, our study projected a network of drug-gene interactions for discovered genes and presented relevant prospective biomarkers for the prognosis of patients with stomach cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology, Institute of Sciences and High Technology and Environmental Sciences, Graduate University of Advanced Technology, End of Haft Bagh-e-Alavi Highway, Kerman, Iran.
- Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
- Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
- Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
- Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran.
- Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
Zitieren
APA
Askari, N., Salek Esfahani, B., Parvizpour, S., Shafieipour, S., & Hadizadeh, M. (2023). Long non-coding RNAs as potential biomarkers or therapeutic targets in gastric cancer. Gastroenterology and hepatology from bed to bench., 16(3), 297-306. https://doi.org/10.22037/ghfbb.v16i2.2701
Vancouver
Askari N, Salek Esfahani B, Parvizpour S, Shafieipour S, Hadizadeh M. Long non-coding RNAs as potential biomarkers or therapeutic targets in gastric cancer. Gastroenterology and hepatology from bed to bench.. 2023;16(3):297-306. doi:10.22037/ghfbb.v16i2.2701
BibTeX
@article{Askari2023,
author = {Askari, Nahid and Salek Esfahani, Behnaz and Parvizpour, Sepideh and Shafieipour, Sara and Hadizadeh, Morteza},
title = {Long non-coding RNAs as potential biomarkers or therapeutic targets in gastric cancer},
journal = {Gastroenterology and hepatology from bed to bench.},
year = {2023},
volume = {16},
number = {3},
pages = {297--306},
doi = {10.22037/ghfbb.v16i2.2701}
}
EUVIMED